Literature DB >> 10896645

Control group selection is an important but neglected issue in studies of antibiotic resistance.

A D Harris, M H Samore, Y Carmeli.   

Abstract

Mesh：

Year:  2000        PMID： 10896645     DOI： 10.7326/0003-4819-133-2-200007180-00018

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

Review 1.  Methods and issues in studies of CRE.

Authors:  Scott R Evans; Anthony D Harris
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

2.  Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Authors:  Kenneth M Wener; Vered Schechner; Howard S Gold; Sharon B Wright; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

3.  Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Authors:  Peter W Kim; Anthony D Harris; Mary-Claire Roghmann; J Glenn Morris; Arjun Strinivasan; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  Antimicrobial use and antimicrobial resistance: a population perspective.

Authors:  Marc Lipsitch; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

5.  The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.

Authors:  Maureen K Bolon; Sharon B Wright; Howard S Gold; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

6.  Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.

Authors:  Dror Marchaim; Shiri Navon-Venezia; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

Review 7.  Economic impact of antimicrobial resistance.

Authors:  J E McGowan
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

8.  Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.

Authors:  Yehuda Carmeli; George M Eliopoulos; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

9.  Outcome of ICU patients with Clostridium difficile infection.

Authors:  Jean-Ralph Zahar; Carole Schwebel; Christophe Adrie; Maité Garrouste-Orgeas; Adrien Français; Aurélien Vesin; Molière Nguile-Makao; Alexis Tabah; Kevin Laupland; Alban Le-Monnier; Jean-François Timsit
Journal:  Crit Care       Date:  2012-11-05       Impact factor: 9.097

10.  Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.

Authors:  Stephen G Weber; Howard S Gold; David C Hooper; A W Karchmer; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.